N, N-dimethyltryptamine (DMT) in rodent brain: Concentrations, distribution, and recent pharmacological data

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Psychedelic drugs, including N, N-dimethyltryptamine (DMT), are gaining renewed clinical interest.
• Older studies on psychedelic drug data are being re-evaluated in light of new discoveries.
• Recent research highlights DMT's interactions with rat brain neurons and specific brain areas.

Purpose of the Study:

• To investigate the neurobiological mechanisms of DMT, particularly its role as a neuroplastogen.
• To explore the therapeutic potential of DMT in neuropsychiatric disorders.
• To elucidate DMT's binding interactions with intracellular sigma-1 and 5-HT2a receptors.

Main Methods:

• Analysis of existing rodent brain DMT concentration data.
• Examination of recent findings on DMT receptor interactions in rat brain neurons.
• Review of studies on psychedelic-induced neuroplasticity via sigma-1 and 5-HT2a receptor activation.

Main Results:

• DMT acts as a neuroplastogen, promoting neuroplasticity through sigma-1 and intracellular 5-HT2a receptor activation.
• DMT binds to sigma-1 receptors (endoplasmic reticulum) and intracellular 5-HT2a receptors (Golgi apparatus) in cortical neurons.
• DMT may be the endogenous ligand for intracellular 5-HT2a receptors, potentially explaining subjective psychedelic effects and natural DMT roles.

Conclusions:

• DMT's interaction with intracellular sigma-1 and 5-HT2a receptors defines its role as a neuroplastogen.
• DMT's proposed function as the endogenous ligand for intracellular 5-HT2a receptors offers insights into its physiological roles and psychedelic effects.
• Further research suggests DMT's involvement in brain development and its regulation by stress-induced adaptive systems.